Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Cellectis S.A. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 27
- −5 vs. Q1 2026
- Shares held
- 9.48M
- −767.5K (−7.5%) vs. Q1 2026
- Total value
- $28.4M
- −$4.04M (−12.4%) vs. Q1 2026
- New holders
- 3
- 2 more added
- Sold out
- 8
- 9 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| B Group, Inc. | 3,281,501 | $9.84M | 5.59% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 2,741,853 | $8.23M | 0.34% | −2,245−0.1% | Reduced |
| UBS Asset Management Americas Inc | 2,644,881 | $7.93M | 0.00% | −533,739−16.8% | Reduced |
| Nomura Asset Management International Inc. | 226,875 | $681.0K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 225,444 | $676.3K | 0.00% | −116,079−34.0% | Reduced |
| Morgan Stanley | 85,455 | $256.4K | 0.00% | −1,321−1.5% | Reduced |
| LPL Financial LLC | 84,415 | $253.2K | 0.00% | +70+0.1% | Added |
| Susquehanna International Group, LLP | 50,453 | $151.4K | 0.00% | −15,489−23.5% | Reduced |
| BNP Paribas Arbitrage, SA | 40,100 | $120.3K | 0.00% | −900−2.2% | Reduced |
| UBS Group AG | 33,926 | $101.8K | 0.00% | +4,152+13.9% | Added |
| Delaney Dennis R | 24,000 | $72.0K | 0.02% | 00.0% | Unchanged |
| Rhumbline Advisers | 14,328 | $43.0K | 0.00% | −757−5.0% | Reduced |
| XTX Topco Ltd | 12,282 | $36.8K | 0.00% | −3,987−24.5% | Reduced |
| Harbour Investments, Inc. | 4,500 | $13.5K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 3,600 | $10.8K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 3,150 | $9.45K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1,558 | $5.00K | 0.00% | +1,558 | New |
| Atlantic Union Bankshares Corp | 1,500 | $4.50K | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 500 | $1.50K | 0.00% | 00.0% | Unchanged |
| POM Investment Strategies, LLC | 495 | $1.49K | 0.00% | 00.0% | Unchanged |
| GAMMA Investing LLC | 463 | $1.39K | 0.00% | −271−36.9% | Reduced |
| Advisor Group Holdings, Inc. | 100 | $300 | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 75 | $225 | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 49 | $147 | 0.00% | +49 | New |
| Jones Financial Companies LLLP | 50 | $142 | 0.00% | +50 | New |
| EverSource Wealth Advisors, LLC | 13 | $39 | 0.00% | 00.0% | Unchanged |
| CWM Advisors, LLC | 6 | $18 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −44,315−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −41,112−100.0% | Sold out |
| Lido Advisors, LLC | 0 | $0 | 0.00% | −10,094−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,797−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −944−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −224−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −97−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |